200 - 3650 GILMORE WAY, BURNABY, A1
Market cap: $3.3B (2/08/2026)
Price: $42.43
Xenon Pharmaceuticals Increases Share Reserve in 2025 Inducement Plan
Reports Third Quarter 2025 Financial Results & Business Update
Amended material disclosure
Announces Appointment of Tucker Kelly as Chief Financial Officer
Reports Second Quarter 2025 Financial Results & Business Update
Changes in Board, Management or Compensation
News
Financial Results, Reg. FD
Q3
Q2
Q1
FY 2024
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Free Writing Prospectus
Confidential Treatment Order
Correspondence
Submission Upload